{
    "code": "02022712",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022712",
    "time": "2019-10-04 03:14:37",
    "許可證字號": "衛署藥輸字第022712號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/12\/21",
    "發證日期": "88\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202271201",
    "中文品名": "艾黴素注射液",
    "英文品名": "ADRIAMYCIN INJ. 2MG\/ML",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "270注射劑",
    "包裝": "5ML,10ML,25ML塑膠小瓶 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "DOXORUBICIN HYDROCHLORIDE",
    "主製造廠": {
        "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
        "申請商地址": "新北市淡水區中正東路二段１７７號",
        "主製造廠": "",
        "製造廠名稱": "FAU0034000  PFIZER (PERTH) PTY LIMITED"
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000620",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Adriamycin LLD Australia 20140610-3-107-10-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=009&Type=9"
        },
        {
            "title": "Adriamycin 2mgml (021712) for TFDA-108-01-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=009&Type=8"
        }
    ]
}